吉華集團(603980.SH):終止部分募投項目
格隆匯12月31日丨吉華集團(603980.SH)公佈,本次擬終止項目名稱:“年產10萬噸染料及中間體產業轉型提升技術改造項目”及“年產3000噸1-氨基蒽醌技術改造項目”。截至2024年12月21日,本次擬終止的募投項目剩餘募集資金合計33,453.37萬元(含理財收益及利息收入及扣減手續費淨額累計人民幣7,517.34萬元,具體金額以當日銀行結算後實際金額為準)。本次募投項目終止後,募集資金將繼續存放於募集資金專户,並繼續按照募集資金管理要求進行存放和管理。未來公司將積極籌劃、尋找合適的投資方向,科學、審慎地進行項目可行性分析,在保證投資項目具有較好市場前景和盈利能力的前提下,按照相關規定履行審批及披露程序後使用募集資金,以提高募集資金使用效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.